United States Sexually-Transmitted Diseases (STD) Diagnostic Testing Market 2016: Emerging Opportunities and Growth Strategies for Suppliers

Nov 03, 2015, 13:10 ET from Research and Markets

DUBLIN, Nov. 3, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/stjzwq/2016_us) has announced the addition of the "2016 US Sexually-Transmitted Diseases (STD) Diagnostic Testing Market: Emerging Opportunities and Growth Strategies for Suppliers" report to their offering.

This new 280-page report presents detailed analysis of the US STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales projections for Hospitals, Commercial, Physician Offices, and Public Health Labs.

In addition to market share and sales forecasts, the report:

- Examines market applications of Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; - Reviews features and operating characteristics of major analyzers used for STD testing; - Profiles key suppliers and potential market entrants developing innovative technologies and products; and - Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.

Companies Mentioned

- Abbott - Affymetrix - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - Bio-Rad - Cepheid - Diamedix - DiaSorin - Eiken Chemical - Elitech Group - Enzo Biochem - Fujirebio - Grifols - Hologic/Gen-Probe - ID Biomedical/GSK - Kreat

For more information visit http://www.researchandmarkets.com/research/stjzwq/2016_us

Media Contact:

Laura Wood, +353-1-481-1716, press@researchandmarkets.net

 

SOURCE Research and Markets



RELATED LINKS

http://www.researchandmarkets.com